1-4 of 4
Mark Bosch, MD
Close
Sort by
Journal Articles

Compliance with Guidelines for Management of Chronic Myeloid Leukemia in Saskatchewan, Canada

Dwip Maheshkumar Prajapati, MD, Julie Stakiw, MD, Mark Bosch, MD FRCPC
Journal: Blood
Blood (2015) 126 (23): 5164.
https://doi.org/10.1182/blood.V126.23.5164.5164
Published: 2015
Journal Articles

Reduced Intensity Versus Myeloablative Conditioning for Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia

Donna Fan, MDcal Student, Waleed Sabry, MD MSc, PhD, Julie Stakiw, MD, Rebecca Ellyn MacKay, MD, Mark Bosch, MD FRCPC, Sabuj Sarker, Mohamed Elemary, MD MSc,PhD
Journal: Blood
Blood (2014) 124 (21): 5857.
https://doi.org/10.1182/blood.V124.21.5857.5857
Published: 2014
Journal Articles

Immune Reconstitution After Antithymocyte Globulin (ATG)-Conditioned Hematopoietic Cell Transplantation (HCT)

Mark Bosch, MD, FRCPC, Manveer Dhadda, Mette Hoegh-Petersen, MD, Yiping Liu, Laura M Hagel, Peter Podgorny, Alejandra Ugarte-Torres, MD, Joanne Luider, Iwona Auer-Grzesiak, MD, FRCPC, Adnan Mansoor, MD, FRCPC, James A Russell, Jan Storek, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 1981.
https://doi.org/10.1182/blood.V118.21.1981.1981
Published: 2011
Journal Articles

RAP Trial: Ringer's Lactate and Packed Red Blood Cell Transfusion, An in Vitro Study and Chart Review.

Lauren Bolster, MD, Mark Bosch, MD, Brian Brownbridge, MD, Anurag Saxena, MD
Journal: Blood
Blood (2009) 114 (22): 2105.
https://doi.org/10.1182/blood.V114.22.2105.2105
Published: 2009